Global Drug Delivery Devices Market 2024-2028
Drug Delivery Devices Market 2024-2028
The drug delivery devices market is forecasted to grow by USD 85.1 bn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic conditions, increased strategic developments, and increase in regulatory approvals for drug delivery devices.
Technavio's drug delivery devices market is segmented as below:
By Route Of Administration
- Oral
- Injectable
- Pulmonary
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising adoption of self-injectable devices as one of the prime reasons driving the drug delivery devices market growth during the next few years. Also, growing adoption of advanced drug delivery systems and development of new drugs and vaccines for covid-19 will lead to sizable demand in the market.
The report on the drug delivery devices market covers the following areas:
- Drug Delivery Devices Market sizing
- Drug Delivery Devices Market forecast
- Drug Delivery Devices Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug delivery devices market vendors that include 3M Co., AbbVie Inc., Antares Pharma Inc., AptarGroup Inc., Becton Dickinson and Co., Biocorp, Elcam Medical Group, F. Hoffmann La Roche Ltd., Insulet Corp., Johnson and Johnson Inc., Koch Industries Inc., Merck KGaA, Nemera Group, Novartis AG, Pfizer Inc., SHL Medical AG, Teva Pharmaceutical Industries Ltd., uniQure NV, and West Pharmaceutical Services Inc.. Also, the drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.